COCH - Envoy Medical, Inc.

Insider Purchase by Brynelsen Charles (Dir)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

1 month ago, Brynelsen Charles, serving as Dir at Envoy Medical, Inc. (COCH), purchased 1,000,000 shares at $0.40 per share, for a total transaction value of $400,000.00. Following this transaction, Brynelsen Charles now holds 1,050,000 shares of COCH.

The trade was executed on Thursday, February 12, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, February 17, 2026, 5 days after the trade was made.

Envoy Medical, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Brynelsen Charles

Brynelsen Charles

Dir

Charles (Chuck) R. Brynelsen, age 68, is Chairman of the Board and Independent Director at Envoy Medical, Inc. (Nasdaq: COCH), having joined the board in 2023.[[1]](https://fintool.com/app/research/companies/COCH/people/chuck-brynelsen)[[2]](https://ir.envoymedical.com/governance/board-of-directors) He recently engaged in significant insider trading, including purchasing 1,000,000 Class A shares at $0.40 on February 12, 2026, increasing his direct holdings to 1,050,000 shares, along with prior buys such as 38,000 shares in May 2025.[[5]](https://www.stocktitan.net/sec-filings/COCH/form-4-envoy-medical-inc-insider-trading-activity-20717eaac95e.html)[[6]](https://www.ainvest.com/news/envoy-medical-director-brynelsen-charles-buys-56000-shares-2505/) Brynelsen brings over four decades of medical device leadership, notably as President of Abbott Vascular (2017–2021), President of Medtronic Early Technologies (2015–2016), Global President of Covidien Early Technologies (2013–2015), and CEO of IntraPace (2005–2012).[[1]](https://fintool.com/app/research/companies/COCH/people/chuck-brynelsen)[[2]](https://ir.envoymedical.com/governance/board-of-directors)[[3]](https://www.envoymedical.com/news/envoy-medical-announces-proposed-board-slate-of-experienced-medical-device-and-financial-leaders) He held various commercial, corporate, international, and general management roles at Medtronic from 1981–2005.[[1]](https://fintool.com/app/research/companies/COCH/people/chuck-brynelsen) Currently, he serves as Venture Partner at SpringRock Ventures (since 2015) and has directed private firms like Alebra Technologies (since 2010) and Neuspera Medical (2022–2023).[[1]](https://fintool.com/app/research/companies/COCH/people/chuck-brynelsen)[[2]](https://ir.envoymedical.com/governance/board-of-directors)[[3]](https://www.envoymedical.com/news/envoy-medical-announces-proposed-board-slate-of-experienced-medical-device-and-financial-leaders) Brynelsen earned a BA from Bradley University and an MBA from Northwestern's Kellogg School of Management.[[2]](https://ir.envoymedical.com/governance/board-of-directors)[[3]](https://www.envoymedical.com/news/envoy-medical-announces-proposed-board-slate-of-experienced-medical-device-and-financial-leaders)

View full insider profile →

Trade Price

$0.40

Quantity

1,000,000

Total Value

$400,000.00

Shares Owned

1,050,000

Trade Date

Thursday, February 12, 2026

53 days ago

SEC Filing Date

Tuesday, February 17, 2026

Filed 5 days after trade

HEALTHCAREMEDICAL DEVICES

About Envoy Medical, Inc.

Company Overview

No company information available
View news mentioning COCH

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4070653

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime